The Strategic Check
Corporate investors are making fewer, bigger bets. What Aranca’s and GCV’s Q3 2026 reports mean for founders seeking a strategic check, and for GPs.
Corporate investors are making fewer, bigger bets. What Aranca’s and GCV’s Q3 2026 reports mean for founders seeking a strategic check, and for GPs.
The Two-Year Cliff: What Record Startup Shutdowns Reveal About the Gap Between Rounds
The Stale-Mark Reckoning: What Miro, Airtable and 59% Secondary Discounts Mean for Founders and GPs
The median US VC fund is $10M while the average is $165.4M. What the rise of solo GPs means for emerging managers and founders seeking a first check.
AI agents now write and send investor pitches at scale. What still gets founders noticed, and how GPs can stand out as screening goes AI.
Median seed prices cooled in 2026 while top-tier valuations soared. What the split means for founders and GPs, and why your lead shapes price and close.
LPs are getting little cash back, so they re-up with GPs they know. What 2026’s DPI drought means for emerging managers and founders raising now.
A spreadsheet can tell you who you contacted. A CRM can tell you when you last spoke. A data room can tell you whether someone opened your deck. All useful. None of them can answer the questions that determine whether your Seed or Series A raise works: That is fundraising […]
Imagine you are a founder with six months of runway. You have built the product. You have early traction. You know additional capital could change the future of your company. You expect fundraising to take six weeks. Then six weeks become three months. Three months become six. Your product roadmap […]
The Blueprint for Opportunity: A Look at the Powerful Intelligence Engine We’re Building for You It’s been an incredibly productive and exciting period of development here at ConnectLab.live. Behind the scenes, we’ve been focused on a single mission: transforming the platform from a powerful networking tool into a proactive intelligence […]